Lymphoma News and Research

RSS
Lymphoma is cancer that begins in cells of the immune system. There are two basic categories of lymphomas. One kind is Hodgkin lymphoma, which is marked by the presence of a type of cell called the Reed-Sternberg cell. The other category is non-Hodgkin lymphomas, which includes a large, diverse group of cancers of immune system cells. Non-Hodgkin lymphomas can be further divided into cancers that have an indolent (slow-growing) course and those that have an aggressive (fast-growing) course. These subtypes behave and respond to treatment differently. Both Hodgkin and non-Hodgkin lymphomas can occur in children and adults, and prognosis and treatment depend on the stage and the type of cancer.
Rogue proteins involved in breast cancer point to potential treatment options

Rogue proteins involved in breast cancer point to potential treatment options

MSK scientists discover epigenetic mechanism promoting breast cancer

MSK scientists discover epigenetic mechanism promoting breast cancer

Study identifies potential risks for mothers who are cancer survivors

Study identifies potential risks for mothers who are cancer survivors

TSRI researchers develop novel drug delivery method for treating cancers

TSRI researchers develop novel drug delivery method for treating cancers

New technique opens door for biochemists to create better therapeutic antibodies

New technique opens door for biochemists to create better therapeutic antibodies

MLL, IBM and Illumina collaborate to build new cognitive technology prototype for improving leukemia treatment

MLL, IBM and Illumina collaborate to build new cognitive technology prototype for improving leukemia treatment

Study establishes ENL protein as potential drug target for acute myeloid leukemia

Study establishes ENL protein as potential drug target for acute myeloid leukemia

Combination of epigenetic and immune-based treatments could lead to better blood cancer therapies

Combination of epigenetic and immune-based treatments could lead to better blood cancer therapies

UNC Lineberger achieves major milestone with launch of cellular immunotherapy program

UNC Lineberger achieves major milestone with launch of cellular immunotherapy program

Scientists identify potential therapeutic target for aggressive lymphomas

Scientists identify potential therapeutic target for aggressive lymphomas

Scientists reveal how gluten plays role in development of rare form of cancer for coeliac patients

Scientists reveal how gluten plays role in development of rare form of cancer for coeliac patients

Novel antiviral drug can protect transplant patients against CMV infections

Novel antiviral drug can protect transplant patients against CMV infections

Research: Biomaterials that mimic bone marrow can alter blood cell development

Research: Biomaterials that mimic bone marrow can alter blood cell development

Research may show new ways to repress inflammation at outset

Research may show new ways to repress inflammation at outset

Researchers examine risk factors for B Cell Non-Hodgkin Lymphoma in Israeli, Palestinian populations

Researchers examine risk factors for B Cell Non-Hodgkin Lymphoma in Israeli, Palestinian populations

Doctors use targeted molecular drugs to treat fatal cancerous blood syndromes

Doctors use targeted molecular drugs to treat fatal cancerous blood syndromes

Radiotherapy for breast cancer linked to greater risk of second primary lung cancer

Radiotherapy for breast cancer linked to greater risk of second primary lung cancer

Research shows how protein component of Epstein-Barr virus promotes development of cancer

Research shows how protein component of Epstein-Barr virus promotes development of cancer

New drug offers hope for patients with bladder cancer

New drug offers hope for patients with bladder cancer

Genetic profiling of blood cells can predict response to stem cell transplant for patients with MDS

Genetic profiling of blood cells can predict response to stem cell transplant for patients with MDS